Ribosomal Protein S6 Kinase and PKC in Human Mammary Tumor Cells
It is well established that 17-β estradiol (E2) influences the growth of human breast cancer (Patterson et al. 1982; Edwards et al. 1979; Maass and Jonat 1983; Howat et al. 1985), but it is unclear wheter E2 acts directly or indirectly on the proliferation of target cells (Soto and Sonnenschein 1987; Dickson and Lippman 1987; King 1985). At present, there is increasing evidence that polypeptide growth factors (GF) also regulate the growth of human breast cancer (Dickson and Lippman 1987; King 1985; Dickson et al. 1986; Dickson et al. 1986). Therefore, E2 may in part promote the growth through the regulation of autostimulatory and autoinhibitory GFs (Soto and Sonnenschein 1987; Dickson and Lippman 1987; Knabbe et al. 1987). Consequently, the hormone dependency of breast tumor cells may be limited not only to functional estrogen receptors (ER) but also to functional growth factor receptors (GF-R). Such GF-Rs are likely to represent important growth-regulatory elements in the estrogen-induced autocrine or paracrine growth mechanisms of human breast cancer (Fitzpatrick et al. 1984; Macias et al. 1986; Sainsbury et al. 1985; Wyss et al. 1987; Sainsbury et al. 1987; Furlanetto and DiCarlo 1984).
KeywordsEpidermal Growth Factor Receptor Human Breast Cancer Cell Human Breast Cancer Cell Line Mammary Tumor Cell Epidermal Growth Factor Binding
Unable to display preview. Download preview PDF.
- Borner C, Wyss R, Regazzi R, Eppenberger U, Fabbro D (1987) Immunological quantitation of phospholipid/Ca2+-dependent protein kinase of human mammary carcinoma cells: Inverse relationship to estrogen receptors. Int J Cancer 40: 344–348Google Scholar
- Dickson RB, McManaway ME, Lippman ME (1986) Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 232: 15401543Google Scholar
- Engel WL, Young NA (1978) Human breast carcinoma cells in continuous culture: A review, Cancer Res 38: 4327–4339Google Scholar
- Horowitz KH, Zava DT, Arulasanam KT, Jensen EM, McGuire WL (1987) Steroid receptor analysis of nine human breast cancer cell lines. Cancer Res 38: 2434–2437Google Scholar
- King RJB (1985) In: Cavalli F (ed) Endocrine Therapy of Breast Cancer: Experimental strategies for studying the development of breast cancer with special reference to steroid hormones, growth factors and oncogenes. Springer, Berlin Heidelberg New York Tokyo, pp 5–26Google Scholar
- Küng W, Silber E, Novak-Hofer I, Eppenberger U (1986) Effects of hormones and growth factors on the growth of six human breast cancer cell lines in defined media. In: Eppenberger U, Fabbro D, Schäfer P (eds) Contributions to oncology, vol. 23. Karger, Basel, pp 26–32Google Scholar
- Novak-Hofer I, Küng W, Fabbro D, Eppenberger U (1987) Estrogen stimulates growth of mammary tumor cells ZR-75 without activation of S6 kinase and S6 phosphorylation: difference from epidermal growth factor and a-transforming growth factor-induced proliferation. Eur J Biochem 164: 445–451PubMedCrossRefGoogle Scholar
- Osborn CK, Monaco ME, Lippman ME, Kahn CR (1978) Correlation among insulin binding, degradation and biological activity in human breast cancer cells in long term tissue culture. Cancer Res 38: 94–102Google Scholar
- Patterson JS, Battersby LA, Edwards DG (1982) Review of the clinical pharmacology and international experience with tamoxifen in advanced breast cancer. In: Iacobelli S, (ed) The role of tamoxifen in breast cancer. Raven, New York, p 17Google Scholar
- Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL (1985) Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet: 364–366Google Scholar
- Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL (1987) Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet: 1398–1402Google Scholar
- Soto AM, Sonnenschein C (1987) Cell proliferation of estrogen-sensitive cells: The case for negative control. Endocr Rev 8: 44–53Google Scholar